Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes: Results from a National Screening Program

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Harvard

Grauslund, J, Stokholm, L, Suhr Thykjaer, A, Möller, S, Laugesen, CS, Bek, T, Dornonville de la Cour, M, Heegaard, S, Højlund, K, Kawasaki, R, Hajari, J, Kyvik, KO, Schielke, KC, Rubin, KH & Rasmussen, ML 2022, 'Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes: Results from a National Screening Program', Ophthalmology Science , bind 1, nr. 1, s. 1-9.

APA

Grauslund, J., Stokholm, L., Suhr Thykjaer, A., Möller, S., Laugesen, C. S., Bek, T., Dornonville de la Cour, M., Heegaard, S., Højlund, K., Kawasaki, R., Hajari, J., Kyvik, KO., Schielke, K. C., Rubin, K. H., & Rasmussen, M. L. (2022). Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes: Results from a National Screening Program. Ophthalmology Science , 1(1), 1-9.

CBE

Grauslund J, Stokholm L, Suhr Thykjaer A, Möller S, Laugesen CS, Bek T, Dornonville de la Cour M, Heegaard S, Højlund K, Kawasaki R, Hajari J, Kyvik KO, Schielke KC, Rubin KH, Rasmussen ML. 2022. Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes: Results from a National Screening Program. Ophthalmology Science . 1(1):1-9.

MLA

Vancouver

Author

Grauslund, Jakob ; Stokholm, Lonny ; Suhr Thykjaer, Anne ; Möller, S ; Laugesen, Caroline Schmidt ; Bek, Toke ; Dornonville de la Cour, Morten ; Heegaard, Steffen ; Højlund, K ; Kawasaki, Ryo ; Hajari, Javad ; Kyvik, KO ; Schielke, Katja Christina ; Rubin, K H ; Rasmussen, M L. / Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes: Results from a National Screening Program. I: Ophthalmology Science . 2022 ; Bind 1, Nr. 1. s. 1-9.

Bibtex

@article{80290c0caf1c4e9faf7170fec252632e,
title = "Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes:: Results from a National Screening Program",
abstract = "PurposeIn previous smaller studies, associations were demonstrated between diabetic retinopathy (DR) and obstructive sleep apnea (OSA), but longitudinal relationships have not been evaluated in larger cohorts. The aim of the present study was to assess the cross-sectional and prospective associations between DR and OSA in a national cohort of patients with type 2 diabetes.DesignCross-sectional and 5-year longitudinal registry-based cohort study.ParticipantsFor cases, we included 153 238 patients with type 2 diabetes who had attended diabetic eye screening and were registered in the Danish Registry of Diabetic Retinopathy (DiaBase). Each of these were matched by 5 control participants without diabetes of the same age and gender (n = 746 148).MethodsExposure and outcome data as well as systemic morbidity and use of medications were identified in national registers, including the DiaBase, the Danish National Patient Register, the Danish National Prescription Registry, and the Danish Civil Registration System. The index date was defined as the date of the first DR screening registered in DiaBase.Main Outcome MeasuresExposure was defined as present and level-specific DR, and main outcomes were crude, age- and gender-adjusted, and multivariable adjusted odds ratios (ORs) for prevalent OSA as well as hazard ratios (HR) for 5-year incident OSA and DR.ResultsPatients with type 2 diabetes independently were more likely to have prevalent OSA (OR, 2.01; 95% confidence interval [CI], 1.95–2.08) and to develop OSA within 5 years (HR, 1.55; 95% CI, 1.46–1.64). Patients with type 2 diabetes and DR at baseline were less likely to have prevalent OSA (OR, 0.57; 95% CI, 0.52–0.62) or to demonstrate incident OSA (HR, 0.86; 95% CI, 0.74–0.99). Likewise, patients with OSA had a lower risk to develop DR (HR, 0.83; 95% CI, 0.74–0.92).ConclusionsIn a registry-based national cohort study, patients with type 2 diabetes had a higher risk of OSA. However, a 43% decreased risk of prevalent OSA was demonstrated in patients with DR, and prospectively, OSA and DR both were related inversely with each other.",
author = "Jakob Grauslund and Lonny Stokholm and {Suhr Thykjaer}, Anne and S M{\"o}ller and Laugesen, {Caroline Schmidt} and Toke Bek and {Dornonville de la Cour}, Morten and Steffen Heegaard and K H{\o}jlund and Ryo Kawasaki and Javad Hajari and KO Kyvik and Schielke, {Katja Christina} and Rubin, {K H} and Rasmussen, {M L}",
year = "2022",
language = "English",
volume = "1",
pages = "1--9",
journal = "Ophthalmology Science ",
issn = "2666-9145",
number = "1",

}

RIS

TY - JOUR

T1 - Inverse Cross-sectional and Longitudinal Relationships between Diabetic Retinopathy and Obstructive Sleep Apnea in Type 2 Diabetes:

T2 - Results from a National Screening Program

AU - Grauslund, Jakob

AU - Stokholm, Lonny

AU - Suhr Thykjaer, Anne

AU - Möller, S

AU - Laugesen, Caroline Schmidt

AU - Bek, Toke

AU - Dornonville de la Cour, Morten

AU - Heegaard, Steffen

AU - Højlund, K

AU - Kawasaki, Ryo

AU - Hajari, Javad

AU - Kyvik, KO

AU - Schielke, Katja Christina

AU - Rubin, K H

AU - Rasmussen, M L

PY - 2022

Y1 - 2022

N2 - PurposeIn previous smaller studies, associations were demonstrated between diabetic retinopathy (DR) and obstructive sleep apnea (OSA), but longitudinal relationships have not been evaluated in larger cohorts. The aim of the present study was to assess the cross-sectional and prospective associations between DR and OSA in a national cohort of patients with type 2 diabetes.DesignCross-sectional and 5-year longitudinal registry-based cohort study.ParticipantsFor cases, we included 153 238 patients with type 2 diabetes who had attended diabetic eye screening and were registered in the Danish Registry of Diabetic Retinopathy (DiaBase). Each of these were matched by 5 control participants without diabetes of the same age and gender (n = 746 148).MethodsExposure and outcome data as well as systemic morbidity and use of medications were identified in national registers, including the DiaBase, the Danish National Patient Register, the Danish National Prescription Registry, and the Danish Civil Registration System. The index date was defined as the date of the first DR screening registered in DiaBase.Main Outcome MeasuresExposure was defined as present and level-specific DR, and main outcomes were crude, age- and gender-adjusted, and multivariable adjusted odds ratios (ORs) for prevalent OSA as well as hazard ratios (HR) for 5-year incident OSA and DR.ResultsPatients with type 2 diabetes independently were more likely to have prevalent OSA (OR, 2.01; 95% confidence interval [CI], 1.95–2.08) and to develop OSA within 5 years (HR, 1.55; 95% CI, 1.46–1.64). Patients with type 2 diabetes and DR at baseline were less likely to have prevalent OSA (OR, 0.57; 95% CI, 0.52–0.62) or to demonstrate incident OSA (HR, 0.86; 95% CI, 0.74–0.99). Likewise, patients with OSA had a lower risk to develop DR (HR, 0.83; 95% CI, 0.74–0.92).ConclusionsIn a registry-based national cohort study, patients with type 2 diabetes had a higher risk of OSA. However, a 43% decreased risk of prevalent OSA was demonstrated in patients with DR, and prospectively, OSA and DR both were related inversely with each other.

AB - PurposeIn previous smaller studies, associations were demonstrated between diabetic retinopathy (DR) and obstructive sleep apnea (OSA), but longitudinal relationships have not been evaluated in larger cohorts. The aim of the present study was to assess the cross-sectional and prospective associations between DR and OSA in a national cohort of patients with type 2 diabetes.DesignCross-sectional and 5-year longitudinal registry-based cohort study.ParticipantsFor cases, we included 153 238 patients with type 2 diabetes who had attended diabetic eye screening and were registered in the Danish Registry of Diabetic Retinopathy (DiaBase). Each of these were matched by 5 control participants without diabetes of the same age and gender (n = 746 148).MethodsExposure and outcome data as well as systemic morbidity and use of medications were identified in national registers, including the DiaBase, the Danish National Patient Register, the Danish National Prescription Registry, and the Danish Civil Registration System. The index date was defined as the date of the first DR screening registered in DiaBase.Main Outcome MeasuresExposure was defined as present and level-specific DR, and main outcomes were crude, age- and gender-adjusted, and multivariable adjusted odds ratios (ORs) for prevalent OSA as well as hazard ratios (HR) for 5-year incident OSA and DR.ResultsPatients with type 2 diabetes independently were more likely to have prevalent OSA (OR, 2.01; 95% confidence interval [CI], 1.95–2.08) and to develop OSA within 5 years (HR, 1.55; 95% CI, 1.46–1.64). Patients with type 2 diabetes and DR at baseline were less likely to have prevalent OSA (OR, 0.57; 95% CI, 0.52–0.62) or to demonstrate incident OSA (HR, 0.86; 95% CI, 0.74–0.99). Likewise, patients with OSA had a lower risk to develop DR (HR, 0.83; 95% CI, 0.74–0.92).ConclusionsIn a registry-based national cohort study, patients with type 2 diabetes had a higher risk of OSA. However, a 43% decreased risk of prevalent OSA was demonstrated in patients with DR, and prospectively, OSA and DR both were related inversely with each other.

M3 - Journal article

VL - 1

SP - 1

EP - 9

JO - Ophthalmology Science

JF - Ophthalmology Science

SN - 2666-9145

IS - 1

ER -

ID: 70637888